Rare Diseases: Significant Delays in Accessing Treatments for Patients in Greece
This article discusses the challenges faced by patients with rare diseases in Greece regarding access to treatments, emphasizing the impact of the COVID-19 pandemic on healthcare and clinical research.
Debate on polylaminin could clarify the boundaries of science
The discussion surrounding the Brazilian clinical research on polylaminin highlights both the potential benefits and limitations of the molecule, which may offer hope in treating severe spinal injuries.
Use of polylaminin is monitored in real time by society: 'Like a Big Brother', says researcher
Research on polylaminin, a substance being studied as a possible treatment for spinal cord injuries, is closely monitored by society, according to lead researcher Tatiana Sampaio.
South Africa: "Ethics, Trust, and the Future of Pediatric HIV Cure"
A recent webinar addressed the ethical and scientific considerations in pediatric HIV cure research, highlighting the role of people living with HIV in this field.
Research on new medications, such as polylaminin, must follow strict international rules
The development of new medications, including polylaminin, requires adherence to strict international guidelines, particularly in clinical trials that involve control groups to assess efficacy and safety.
A single daily pill against HIV to replace more complex treatments in patients with resistances
New research suggests that a single daily pill combining two medications may effectively substitute more complex HIV treatments.
Polylaminin: How the studies were conducted, what are the results so far, and what does Anvisa say? Understand
A groundbreaking Brazilian study on polylaminin shows promising results in restoring movement after severe injuries, with a pivotal clinical study approved by Anvisa set to begin next month.
Uganda: JCRC Launches Shs15bn Drive to Build Uganda's First Bone Marrow Transplant Centre
The Joint Clinical Research Centre has initiated a Shs15 billion fundraising campaign to establish Uganda's first bone marrow transplant center to improve treatment for sickle cell disease and blood disorders.
Men addicted to sex, pornography, and compulsive masturbation – this study is for you
A groundbreaking clinical trial in Poland is set to examine the pharmacological treatment of compulsive sexual behaviors, particularly focusing on compulsive masturbation.
Scientific societies call for caution and precision in the debate over poly-laminin
Scientific societies in Brazil urge caution in the discussion surrounding poly-laminin, a protein under investigation for spinal cord injury regeneration, emphasizing the importance of distinguishing experimental research from established clinical application.
Hope Against Triple Negative Breast Cancer: Experimental Vaccine Shows Positive Results
An experimental mRNA vaccine shows promising outcomes in a small trial for triple-negative breast cancer patients.
Fast method for treating depression? Scientists published promising research results
Research indicates that a single dose of dimethyltryptamine (DMT) could effectively treat severe depression that is resistant to conventional antidepressants.
Not all depression is the same: up to 30% of cases may have metabolic-related manifestations
Research indicates that between 20% and 30% of individuals with depression may experience a specific type characterized by low-grade inflammation and metabolic changes, known as immunometabolic depression.
INSP and Grupo PiSA promote clinical research made in Mexico
The National Institute of Public Health (INSP) and Grupo PiSA held a meeting to collaborate on enhancing clinical research and scientific development in Mexico.
Scientists have a new idea for fighting depression. This method is a chance for many patients
Researchers propose a new approach to combat depression, particularly focusing on a subtype linked to immune system dysregulation, supported by recent clinical trial findings on anti-inflammatory treatments.
Grupo Amil, by Seripieri, and Lula's government close partnership
Grupo Amil has partnered with the Ministry of Health to lend its Edson Bueno Center for research and innovation to the government, aiming to enhance SUS professional training and Brazil's role in international clinical research.
Day of Fight Against Cancer. Scientist: It is worth paying attention to what precedes clinical trials
The article discusses the increasing cancer challenges, focusing on the importance of understanding drug effectiveness before clinical trials, as cancer remains a leading cause of death in Poland.
A Spaniard leads a breakthrough that could accelerate the HIV vaccine
A Spanish scientist has made significant progress that could lead to accelerated development of an HIV vaccine, pending funding for human trials.
Polylaminin: a molecule discovered in Brazil 'by chance' that became hope to reverse spinal cord injuries
Polylaminin, a modified version of the naturally occurring laminin protein, is being studied as a new potential treatment for spinal cord injury victims in Brazil, although it is still in early clinical trial phases.
A vaccine to prevent colon cancer shows promising results
A preventive vaccine, Nous-209, shows promising results in initial trials with patients at a significantly higher risk of developing tumors.
Breakthrough report on ADHD. We know which therapies really work and which are a waste of time
A new umbrella review published in 'The BMJ' evaluates the effectiveness of various ADHD therapies based on a comprehensive analysis of clinical trials.